Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patien...

por Akbar, Shayista, Raza, Afsheen, Mohsin, Reyad, Kanbour, Aladdin, Qadri, Shahnaz, Parray, Aijaz, Zar Gul, Abdul Rehman, Philip, Anite, Vijayakumar, Suma, Merhi, Maysaloun, Hydrose, Shereena, Inchakalody, Varghese Philipose, Al-Abdulla, Rajaa, Abualainin, Wafa, Sirriya, Shaza Abu, Al-Bozom, Issam, Uddin, Shahab, Khan, Omar Muhammad, Mohamed Ibrahim, Mohamed Izham, Al Homsi, Ussama, Dermime, Said
Publicado 2023

Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression

por Raza, Afsheen, Mohsen, Reyad, Kanbour, Aladdin, Zar Gul, Abdul Rehman, Philip, Anite, Vijayakumar, Suma, Hydrose, Shereena, Prabhu, Kirti S., Al-Suwaidi, Aisha Khamis, Inchakalody, Varghese Philipose, Merhi, Maysaloun, Abo El-Ella, Dina M., Tauro, Melissa Annrose, Akbar, Shayista, Al-Bozom, Issam, Abualainin, Wafa, Al-Abdulla, Rajaa, Sirriya, Shaza Abu, Hassnad, Suparna, Uddin, Shahab, Mohamed Ibrahim, Mohamed Izham, Al Homsi, Ussama, Demime, Said
Publicado 2023